Overview

A Randomized Study Investigating Oral Desmetramadol Dose Proportionality and Food Effect In Normal Human Subjects

Status:
Completed
Trial end date:
2021-01-18
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate in healthy human subjects how much desmetramadol (Omnitram) gets in the blood after different oral doses are taken with or without food.
Phase:
Phase 1
Details
Lead Sponsor:
Syntrix Biosystems, Inc.
Collaborators:
Celerion
National Institute on Drug Abuse (NIDA)